The Liver Meeting 2016, organised by the American Association for the Study of Liver Diseases (AASLD), took place in Boston, USA, from 11-15 November 2016.

Conference highlights

Triple DAA combination

8-week triple DAA combo cures most people with genotype 1-6 hepatitis C.

HIV/HCV co-infection

People with HIV/HCV co-infection see good cure rates in real-world practice in Madrid.

Pangenotypic regimen

AbbVie pangenotypic combination cures 98% or above across genotypes.


HCV genotype 3

AbbVie pangenotypic combination cures almost all hard-to-treat people with HCV genotype 3.

New hepatitis B treatment

Tenofovir alafenamide approved for hepatitis B, works well with less effect on bones.

Grazoprevir triple regimen

Grazoprevir triple regimen demonstrates high cure rates, even for hard-to-treat people.


aidsmap news

There is no aidsmap news from AASLD 2016 yet. Showing all aidsmap news instead.

Editors' picks from other sources

There are no Editors' Picks from AASLD 2016 yet. Showing all Editors' picks instead.

News bulletins

Sign up for our email bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

Official conference website

Find out more on the official conference website.

Visit the conference website >
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.